- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02158793
Craniomaxillofacial Allotransplantation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is to perform facial transplants in patients with severe facial deformities or facial wounds from traumatic injuries. The transplant is to help reconstruct a person's damaged face. The aim of the transplant is to provide patient a more normal appearance . Additionally we aim to restore functioning, movement, and sensation of their face including that of the lips, mouth, and eyes.
There are some procedures in plastic and reconstructive surgery that can repair the look of a patient's face, but often can't replace the movement and use of the face. Currently, patients with severe facial deformities would undergo several reconstructive surgeries with their own tissues, called autologous transplant. Conventional reconstruction method requires multiple surgeries in order to form and shape the transplanted tissue. Because this type of reconstruction is limited, it does not provide a reliable return in function, sensation, and appearance for the damaged parts of the face.
This study uses a composite tissue allograft , or face transplant from a donor who is brain dead such as in heart, kidney and liver transplants. The damaged parts of the face could return movement as well. Transplanted patients are required to take lifelong immunosuppression drugs which have risks, which are still a consideration when deciding to choose this option for correcting severe facial deformities.
We will conduct the surgery and prospectively follow the patient to monitor signs of rejection of the transplanted face. Additionally, patients will be constantly evaluated for clinical and functional outcomes and ensure that optimal results are achieved.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Thomas Calahan
- Phone Number: (929) 455-5826
- Email: Thomas.Calahan@nyulangone.org
Study Contact Backup
- Name: Aimee Chow
- Phone Number: (212) 263-4355
- Email: Aimee.Chow@nyulangone.org
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- Recruiting
- NYU Langone Medical Center
-
Contact:
- Nicole Sweeney, NP
- Phone Number: 646-501-4464
- Email: Nicole.Sweeney@nyumc.org
-
Contact:
- Tiffany Drummond, BS
- Phone Number: 212-263-4867
- Email: tiffany.drummond@nyumc.org
-
Principal Investigator:
- Eduardo D Rodriguez, MD, DDS
-
Sub-Investigator:
- Alexes Hazen, MD
-
Sub-Investigator:
- Daniel Ceradini, MD
-
Sub-Investigator:
- Jamie Levine, MD
-
Sub-Investigator:
- Pierre Saadeh, MD
-
Sub-Investigator:
- Bruce Gelb, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Signed and dated all required IRB approved consent forms
- Male or female recipient between the ages of 18-64 years. * Recipients do not need to be same gender as donor*
- Facial composite tissue defect requiring facial transplantation as determined by the treating Plastic and Reconstructive Surgeon. Inclusive facial functional subunit tissue loss. Including but not limited to irreparable peri-oral, peri-orbital, and peri-nasal damage.
- Patient has been encouraged to seek a second opinion from a Plastic Surgeon with specialized focus in facial reconstruction.
- Willingness to participate in ongoing psychiatric, psychological and social work evaluations prior to and post-transplant surgery
- The subject is able to complete pre-transplant examination and screening procedures.
- Patient has been approved by Patient Selection Committee for placement on the recipient waiting list
- The subject is willing to continue immunosuppression regimen as directed by treating physician.
- Subject is willing and able to return to follow-up visits as described in treatment plan.
- Subjects must have autogenous tissue options available for reconstruction in event of graft failure.
- Normal GFR (glomerular filtration rate) >60
- Negative pregnancy test within 48hrs of transplant for women of childbearing age and who agree to use a reliable form of contraception for one year following transplant.
Exclusion criteria:
- Subject has an uncontrolled infection
- Serious co-morbidities
- Positive serology for HIV; Hepatitis B/C Antigen
- Active malignancy within 5 years with the exclusion of non-melanoma
- Subject has active substance abuse/ alcoholism
- Active Severe Psychiatric Illness
- Cognitive limitations affecting the patient's ability to provide informed consent
- Recent history of medical nonadherence
- Unstable social situation as evidence by lack of stable housing and/or lack of a supportive significant other.
- Recent history of medical non-adherence.
- Lack of stable housing and/or supportive significant other/caregiver throughout all phases of the study
- Currently active smoker within 1 year
- Subjects with any cognitive deficits related to a TBI (traumatic brain injury) and or any organic neurological disorders will not be considered for this protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Face Transplant recipient
Single Arm study, all participants will receive Craniomaxillofacial allotransplantation
|
Transplantation of donor face
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the success of the face transplant
Time Frame: Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
|
We will measure the restoration of function, sensation, and appearance of the transplanted facial segment. These will be measured using various multi-disciplinary evaluations including swallow studies, photography, speech therapy evaluation, Occupational therapy evaluation, electromyogram (EMG) , Nerve Conduction Study (NCS), CT Angiogram, Functional ( Magnetic Resononance Image) MRI, vision exams, pathology samples to check for rejection, Blood tests |
Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate psychological effects of receiving a face transplant
Time Frame: Monthly for 6 months, every 6 months for 2 years, then annually until year 5
|
Psychological outcome will be measured using patient reported outcome tools such as MoCA; BIDQ; SF-36; PHQ-9
|
Monthly for 6 months, every 6 months for 2 years, then annually until year 5
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eduardo Rodriguez, MD, DDS, NYU Langone Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-00550
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Injuries
-
University of UtahCompletedSynkinesis | Facial Asymmetry | Facial Nerve Injuries | Facial Paresis Associated With Facial Nerve Dysfunction
-
Massachusetts General HospitalNot yet recruitingFacial Injuries | Facial Deformity | Facial Trauma
-
Johns Hopkins UniversityRecruitingFacial Injuries | Facial Deformity | Craniofacial Defects | Craniofacial Injuries | Traumatic Wounds and Injuries | Facial TransplantationUnited States
-
NYU Langone HealthRecruitingFacial Injuries | Hand Injuries | Facial Deformity | Craniofacial Injuries | Upper Extremity Injuries | Face InjuriesUnited States
-
University of MichiganRecruitingFacial DefectUnited States
-
University of Texas at AustinCompletedFacial LacerationUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownInjury of Facial Nerve, Unspecified Side, Initial Encounter
-
David Grant U.S. Air Force Medical CenterWithdrawnFacial Injuries and Disorders
-
University of PittsburghUnited States Department of DefenseCompletedFacial Injuries | Adipose TissueUnited States
-
Children's Hospitals and Clinics of MinnesotaWithdrawnFacial and Scalp LacerationsUnited States
Clinical Trials on Craniomaxillofacial allotransplantation
-
NYU Langone HealthRecruitingFacial Injuries | Hand Injuries | Facial Deformity | Craniofacial Injuries | Upper Extremity Injuries | Face InjuriesUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Massachusetts General HospitalNot yet recruitingFacial Injuries | Facial Deformity | Facial Trauma
-
Second Affiliated Hospital, School of Medicine,...Zhejiang University; Sir Run Run Shaw Hospital; Xijing Hospital, Air Force Medical...RecruitingKidney Transplant Rejection | Skin GraftChina
-
Methodist Health SystemCompleted
-
Centre Hospitalier Universitaire, AmiensRecruiting
-
Brigham and Women's HospitalRecruitingLimb Amputation | Extremity AmputationUnited States
-
Lawson Health Research InstituteLondon Health Sciences CentreWithdrawn
-
Brigham and Women's HospitalRecruitingAbdominal Wall DefectUnited States
-
Johns Hopkins UniversityRecruiting